References
- ConfavreuxCVukusicSMoreauTAdeleinePRelapses and progression of disability in multiple sclerosisN Engl J Med2000343201430143811078767
- ConfavreuxCVukusicSAdeleinePEarly clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic processBrain2003126Pt 477078212615637
- LerayEYaouanqJLe PageEEvidence for a two-stage disability progression in multiple sclerosisBrain2010133Pt 71900191320423930
- SormaniMPRioJTintoreMScoring treatment response in patients with relapsing multiple sclerosisMult Scler201219560561223012253
- RioJRoviraATintoreMEvaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsMult Scler201420121602160824622350
- JongenPJSandersEZwanikkenCAdherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatmentPatient Prefer Adherence2013729330023589682
- HarmarkLvan PuijenbroekEvan GrootheestKIntensive monitoring of duloxetine: results of a web-based intensive monitoring studyEur J Clin Pharmacol201369220921522688722
- BanduraASelf-efficacy: toward a unifying theory of behavioral changePsychol Rev1977842191215847061
- BanduraASocial foundations of thought and action: a social cognitive theoryEnglewood CliffsPrentice-Hall1986
- AmtmannDBamerAMCookKFAskewRLNoonanVKBrockwayJAUW-SES: A new self-efficacy scale for people with disabilitiesArch Phys Med Rehabil201293101757176522575393
- StuifbergenAKBeckerHBlozisSTimmermanGKullbergVA randomized clinical trial of a wellness intervention for women with multiple sclerosisArch Phys Med Rehabil200384446747612690582
- MotlRWSnookEMPhysical activity, self-efficacy, and quality of life in multiple sclerosisAnn Behav Med200835111111518347911
- e-Study Guide for: Strategies for Teaching Learners with Special NeedsReviewsCTEdition 92012 Available from: https://books.google.nl/books?isbn=1467274461Accessed August 30, 2015
- WyniaKMiddelBvan DijkJPde RuiterHde KeyserJReijneveldSAThe Multiple Sclerosis impact Profile (MSIP). Development and testing psychometric properties of an ICF-based health measureDisabil Rehabil200830426127417852244
- WyniaKMiddelBde RuiterHvan DijkJPde KeyserJHReijneveldSAStability and relative validity of the Multiple Sclerosis Impact Profile (MSIP)Disabil Rehabil200830141027103818953748
- WyniaKWijlenAVMiddelBReijneveldSMeilofJChange in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP)Mult Scler201218565466121965423
- VickreyBGHaysRDHarooniRMyersLWEllisonGWA health-related quality of life measure for multiple sclerosisQual Life Res1995431872067613530
- FiskJDRitvoPGRossLHaaseDAMarrieTJSchlechWFMeasuring the functional impact of fatigue: initial validation of the fatigue impact scaleClin Infect Dis199418Suppl 1S79S838148458
- FordHLGerryETennantAWhalleyDHaighRJohnsonMHDeveloping a disease-specific quality of life measure for people with multiple sclerosisClin Rehabil200115324725811386394
- FordHLGerryEJohnsonMHTennantAHealth status and quality of life of people with multiple sclerosisDisabil Rehabil2001231251652111432648
- ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
- TubaroAPucciniFDe NunzioCThe treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic reviewCurr Urol Rep201213533534222886612
- BatesDBurksJGlobeDDevelopment of a short form and scoring algorithm from the validated actionable bladder symptom screening toolBMC Neurol2013137823837535
- BurksJChancellorMBatesDDevelopment and validation of the actionable bladder symptom screening tool for multiple sclerosis patientsInt J MS Care201315418219224453782
- KurtzkeJFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)Neurology19833311144414526685237
- ZhangJWaubantECutterGWolinskyJSGlanzmanREDSS variability before randomization may limit treatment discovery in primary progressive MSMult Scler201319677578123027880
- Grand’MaisonFBhanVFreedmanMSUtility of the Canadian Treatment Optimization Recommendations (TOR) in MS careCan J Neurol Sci201340452753523786735
- Sport MoHWaWet medisch-wetenschappelijk onderzoek met mensen. [Dutch Medical Research Involving Human Subjects Act (WMO)]International Publication Series Health, Welfare and Sport19972134 Available from: http://wetten.overheid.nl/BWBR0009408/geldigheidsdatum_16-10-2015Accessed August 30, 2015 Dutch
- SadovnickADEuropean Charcot Foundation Lecture: the natural history of multiple sclerosis and genderJ Neurol Sci20092861–21519782378
- Koch-HenriksenNSorensenPSThe changing demographic pattern of multiple sclerosis epidemiologyLancet Neurol20109552053220398859
- BoströmIStawiarzLLandtblomAMSex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg)Mult Scler2013191465222711712
- AllaSPearsonJDebernardLMillerDMasonDThe increasing prevalence of multiple sclerosis in New ZealandNeuroepidemiology201442315416024556851
- LahdensuoAGuided self management of asthma – how to do itBMJ1999319721275976010488007
- OralAYalimanARevisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidenceInt J Rehabil Res20133629710423635795